Hematopoiesis, Erythropoiesis, and Erythrocyte Physiology

The red-cell life cycle begins with hematopoietic stem and progenitor cells in marrow, passes through recognizable erythroblast stages, and ends when macrophages clear aged or damaged erythrocytes. Changes across this cycle can appear in the marrow, peripheral blood film, reticulocyte count, bilirubin, haptoglobin, and iron profile.¹

Hematopoietic sites and marrow organization

Human blood production develops in overlapping waves. Early embryonic erythroid cells arise in the yolk sac. Definitive hematopoietic stem cells emerge from hemogenic endothelium in intraembryonic sites that include the aorta-gonad-mesonephros region, then expand chiefly in the fetal liver. Bone marrow becomes the main hematopoietic organ before birth and remains so through adult life.²

In adults, hematopoietically active red marrow is concentrated in the vertebrae, pelvis, ribs, sternum, skull, scapulae, and proximal humeri and femora. Yellow marrow contains more adipose tissue and less hematopoietic activity. Severe, sustained demand can recruit additional marrow and drive extramedullary hematopoiesis in the liver or spleen.¹

Red marrow consists of hematopoietic cords between vascular sinuses. Developing erythroblasts form erythroblastic islands around macrophages that support maturation, handle extruded nuclei, and help supply iron. Megakaryocytes lie next to sinusoidal endothelium and extend platelet-forming processes toward the blood. Granulocytic precursors mature deeper in the cords. Endothelial cells, mesenchymal stromal cells, macrophages, osteolineage cells, extracellular matrix, cytokines, and adhesion molecules together form the marrow niche that regulates stem-cell maintenance and lineage output.^1,3

Stem cells, progenitors, and growth factors

A hematopoietic stem cell can self-renew and produce every mature blood lineage. The classical laboratory map places multipotent progenitors below the stem cell, followed by common myeloid and lymphoid branches and then lineage-restricted progenitors. Colony assays supplied names such as CFU-GEMM, BFU-E, CFU-E, CFU-GM, and CFU-Meg. These names describe growth behavior under defined culture conditions. Single-cell studies show gradual lineage priming and heterogeneous progenitor populations, so the branching map is best read as a teaching model for an underlying process that is continuous.^2,4

Growth-factor effects overlap, and their actions depend on receptor expression and the cell’s stage of commitment. A factor associated with one lineage can also support an earlier multipotent population. BFU-E is less dependent on erythropoietin than CFU-E, but it is not erythropoietin-independent.⁴

Megakaryocyte maturation reverses the usual size pattern. Erythroid and granulocytic precursors generally become smaller as their chromatin condenses, while megakaryocytes grow into large, rare marrow cells under thrombopoietin/MPL signaling. Their endomitotic cell cycle replicates DNA without completed cytokinesis, producing a multilobated polyploid nucleus. Maturation adds α-granules, dense granules, and a demarcation membrane system that supplies membrane for platelet formation. Mature cells extend proplatelets in the marrow sinusoidal niche and release thousands of platelets during their life span. Bone marrow is the primary steady-state site of this process. Detailed platelet activation and primary hemostasis belong with the hemostasis laboratory pathway.^1,5

Erythroid maturation

BFU-E and CFU-E are functional colony-assay designations and lack a distinctive routine light-microscopic appearance. The pronormoblast is the first morphologically recognizable erythroid precursor. From that point forward, cell and nuclear size decrease, chromatin condenses, nucleoli disappear, and cytoplasm changes from RNA-rich blue to hemoglobin-rich pink. The cell expels its nucleus after the orthochromic stage. Residual ribosomal RNA remains in the reticulocyte and produces a reticular network with a supravital stain.^1,4

These dimensions are reference ranges for well-prepared cells and vary with specimen preparation and measurement method.⁶

Two other systems name the same sequence. Rubriblastic terms run rubriblast, prorubricyte, rubricyte, and metarubricyte. Erythroblastic terms use proerythroblast followed by basophilic, polychromatic, and orthochromatic erythroblast. A laboratory should use one naming system consistently.

The nucleus-to-cytoplasm ratio is a visual estimate of relative area. A high ratio means that the nucleus occupies most of the cell. The ratio falls during erythroid maturation because nuclear contraction outpaces the decrease in cell size. Cytoplasmic color gives a second independent clue: ribosomal RNA stains blue, while hemoglobin produces the pink-orange color of a mature red cell.

Oxygen sensing and erythropoietic response

Renal peritubular interstitial fibroblast-like cells produce most erythropoietin after birth. Reduced tissue oxygen stabilizes hypoxia-inducible factor, especially HIF-2α, which increases transcription of the erythropoietin gene. Circulating erythropoietin binds its receptor on committed erythroid progenitors and activates JAK2 and STAT5 signaling. This signal promotes survival of CFU-E cells and early erythroblasts and supports proliferation and differentiation.⁷

The response unfolds in a set order:

1. Tissue hypoxia increases renal erythropoietin production.
2. Erythropoietin preserves and expands responsive erythroid progenitors.
3. Marrow releases reticulocytes earlier and increases total red-cell output.
4. Reticulocytosis and polychromasia become visible as the response reaches peripheral blood.
5. Restored oxygen delivery lowers the erythropoietin stimulus.

Erythroblasts also release erythroferrone during an erythropoietic response. Erythroferrone lowers hepcidin, which increases iron availability for hemoglobin synthesis. An effective marrow response therefore requires adequate accessible iron even when erythropoietin signaling is strong.⁷

Reticulocytes ordinarily finish maturation over about 1 to 2 days after enucleation, including approximately 1 day in peripheral blood. Strong stimulation releases larger, RNA-rich stress reticulocytes. A reticulocyte percentage can therefore appear high while the absolute output remains inadequate for the degree of anemia. An anemia work-up uses the absolute reticulocyte count and, when needed, a production correction to judge the marrow response.

Erythrocyte clearance and iron recycling

A mature erythrocyte circulates for about 120 days. It cannot replace damaged proteins through new protein synthesis, so cumulative metabolic, oxidative, membrane, and mechanical changes reduce its deformability. Macrophages in the spleen, liver, and marrow remove aged or damaged cells and recover their iron. The signals that mark an individual cell for removal are not fully defined.³

Plasma haptoglobin binds cell-free hemoglobin for uptake chiefly by CD163-positive macrophages. Hemopexin binds free heme for receptor-mediated uptake by hepatocytes and macrophages. Significant intravascular hemolysis can exceed these scavenging systems, which explains the fall in haptoglobin and appearance of hemoglobin in plasma and urine.⁸

Splenic macrophages also perform pitting, removing inclusions such as Howell-Jolly bodies while returning the erythrocyte to the circulation. Persistent Howell-Jolly bodies therefore suggest reduced splenic filtration.

Macrophage heme oxygenase opens the heme ring to form biliverdin and releases iron and carbon monoxide. Biliverdin reductase forms unconjugated bilirubin, which travels bound to albumin to the liver. Hepatocyte UGT1A1 conjugates bilirubin for biliary excretion. Macrophage ferroportin exports recovered iron; transferrin carries it back to developing erythroblasts. Erythrocyte recycling supplies far more daily iron to marrow than intestinal absorption.^1,3,9

Membrane, metabolism, and deformability

The erythrocyte’s thin biconcave profile provides excess surface area for its volume. Its flexible membrane skeleton allows an approximately 7 to 8 µm cell to pass through narrow capillaries and splenic slits. Deformability depends on three linked properties: surface-area-to-volume ratio, internal viscosity set largely by hemoglobin concentration, and the mechanical integrity of the membrane skeleton.¹⁰

The lipid bilayer connects to a spectrin-actin network through two major attachment systems. The ankyrin complex includes band 3, protein 4.2, ankyrin, and β-spectrin. The junctional complex includes spectrin, actin, protein 4.1R, and several membrane partners. Defects that weaken bilayer-to-skeleton attachments promote membrane loss and spherocytes. Defects that weaken the spectrin network impair mechanical stability and promote elliptocytes or fragmentation.¹⁰

Mature erythrocytes lack mitochondria and depend on cytosolic glucose metabolism:

ATP-dependent pumps maintain cell volume and low cytosolic calcium. Net cation gain draws water into the cell and reduces the surface-area-to-volume reserve. Net potassium and water loss dehydrates the cell and raises internal viscosity. Either direction can reduce deformability and shorten survival.

Hemoglobin gas transport

Each hemoglobin molecule contains four globin chains and four hemes. Ferrous iron in each heme binds one oxygen molecule reversibly. Interaction among the subunits makes binding cooperative, producing the sigmoid oxygen dissociation curve. P50 is the PO₂ at which hemoglobin is 50% saturated and is about 26 to 27 mm Hg for normal adult blood under standard conditions. A lower P50 indicates higher oxygen affinity; a higher P50 indicates lower affinity and easier tissue unloading.¹¹

Deoxygenated hemoglobin favors the tense state and binds 2,3-BPG between its β chains. Oxygenation shifts hemoglobin toward the relaxed state and displaces 2,3-BPG. The pH effect is the Bohr effect: hydrogen ion binding in metabolically active tissue lowers oxygen affinity and promotes unloading. Fetal hemoglobin binds 2,3-BPG less strongly and therefore has a higher oxygen affinity than adult hemoglobin.¹¹

Most carbon dioxide produced by tissues is carried as bicarbonate. Carbon dioxide enters the erythrocyte, where carbonic anhydrase rapidly forms carbonic acid, which dissociates into hydrogen ion and bicarbonate. Deoxygenated hemoglobin buffers the hydrogen ion. Band 3 exchanges intracellular bicarbonate for plasma chloride, producing the chloride shift. The sequence reverses in pulmonary capillaries. Oxygenation lowers hemoglobin’s capacity to bind hydrogen ions and carbon dioxide, the Haldane effect, and promotes carbon dioxide release into alveolar gas for exhalation.¹²

The Erythrocyte Physiology and the Storage Lesion applies membrane metabolism and oxygen-affinity principles to refrigerated blood components.

References

1. Keohane EM, Preston MM, Mirza KM, Walenga JM, eds. Rodak's Hematology: Clinical Principles and Applications. 7th ed. Elsevier; 2025. Accessed August 28, 2026.
2. Vink CS, Mariani SA, Dzierzak E. Embryonic origins of the hematopoietic system: hierarchies and heterogeneity. HemaSphere. 2022;6(6):e737. doi:10.1097/HS9.0000000000000737
3. Borges MD, Sesti-Costa R. Macrophages: key players in erythrocyte turnover. Hematol Transfus Cell Ther. 2022;44(4):574-581. doi:10.1016/j.htct.2022.07.002
4. Schippel N, Sharma S. Dynamics of human hematopoietic stem and progenitor cell differentiation to the erythroid lineage. Exp Hematol. 2023;123:1-17. doi:10.1016/j.exphem.2023.05.001
5. Asquith NL, Carminita E, Camacho V, et al. The bone marrow is the primary site of thrombopoiesis. Blood. 2024;143(3):272-278. doi:10.1182/blood.2023020895
6. College of American Pathologists. Hematology, Clinical Microscopy, and Body Fluids Glossary. 2025. Accessed August 28, 2026.
7. Bhoopalan SV, Huang LJ, Weiss MJ. Erythropoietin regulation of red blood cell production: from bench to bedside and back. F1000Res. 2020;9:1153. doi:10.12688/f1000research.26648.1
8. Schaer DJ, Vinchi F, Ingoglia G, Tolosano E, Buehler PW. Haptoglobin, hemopexin, and related defense pathways: basic science, clinical perspectives, and drug development. Front Physiol. 2014;5:415. doi:10.3389/fphys.2014.00415
9. Korolnek T, Hamza I. Macrophages and iron trafficking at the birth and death of red cells. Blood. 2015;125(19):2893-2897. doi:10.1182/blood-2014-12-567776
10. Mohandas N, Gallagher PG. Red cell membrane: past, present, and future. Blood. 2008;112(10):3939-3948. doi:10.1182/blood-2008-07-161166
11. Jaafar LS, Kourie CMR, El-Mallah CA, Obeid O. 2,3-Diphosphoglycerate: the forgotten metabolic regulator of oxygen affinity. Br J Nutr. 2025;134(10):803-815. doi:10.1017/S0007114525105345
12. Jennings ML. Cell physiology and molecular mechanism of anion transport by erythrocyte band 3/AE1. Am J Physiol Cell Physiol. 2021;321(6):C1028-C1059. doi:10.1152/ajpcell.00275.2021